Vapotherm (VAPO) Stock Price, News & Analysis

Company Overview

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Key Stats

• Today's Range: $2.16 to $2.17
• 50-Day Range: $2.13 to $2.18
• 52-Week Range: $0.70 to $3.44
• Volume: 51,531 shs
• Average Volume: N/A
• Market Capitalization: $13.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VAPO Stock Analysis - Frequently Asked Questions

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) issued its earnings results on Wednesday, November, 3rd. The company reported ($4.16) earnings per share for the quarter, missing the consensus estimate of ($4.00) by $0.16. The business earned $38.12 million during the quarter, compared to analyst estimates of $32.56 million.

When did Vapotherm's stock split?

Vapotherm's stock reverse split before market open on Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

When did Vapotherm IPO?

Vapotherm (VAPO) raised $60 million in an initial public offering (IPO) on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vapotherm investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Uber Technologies (UBER) and Adobe (ADBE).

Company Calendar

• Last Earnings: 11/03/2021
• Today: 6/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:VAPO
• CIK: 1253176
• Web: www.vapotherm.com
• Phone: (866) 410-9986
• Fax: N/A
• Employees: 290
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($8.51)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$58.19 million
• Net Margins: -76.74%
• Pretax Margin: -76.57%
• Return on Equity: N/A
• Return on Assets: -68.08%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.25
• Quick Ratio: 0.09

Sales & Book Value

• Annual Sales: $68.67 million
• Price / Sales: 0.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($9.01) per share
• Price / Book: -0.24

Miscellaneous

• Outstanding Shares: 6,260,000
• Free Float: 5,273,000
• Market Cap: $13.58 million
• Optionable: No Data
• Beta: -1.11